Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence-Reference-Cited by-同舟云学术

Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence

Published:2012-06-12 Issue:9 Volume:17 Page:1057-1065
ISSN:1360-2276
Container-title:Tropical Medicine & International Health
language:en
Short-container-title:

Author:

Matta Guedes Paulo Marcos,Gutierrez Fredy Roberto Salazar,Nascimento Manuela Sales Lima,Do-Valle-Matta Maria Adelaide,Silva João Santana

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Parasitology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3156.2012.03025.x/fullpdf

Reference63 articles.

1. Adverse events after the use of benznidazole in infants and children with Chagas disease;Altcheh;Pediatrics,2011

2. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology;Andrade;Revista da Sociedade Brasileira de Medicina Tropical,1996

3. Therapy of the chronic phase of the experimental infection by Trypanosoma cruzi with benzonidazole and nifurtimox;Andrade;Revista da Sociedade Brasileira de Medicina Tropical,1989

4. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice;Andrade;Bulletin of the World Health Organization,1991

5. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains;Andrade;Transactions of the Royal Society of Tropical Medicine and Hygiene,1992

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Benznidazole decreases the risk of chronic Chagas disease progression and cardiovascular events: A long-term follow up study;EClinicalMedicine;2021-01

2. Correlation between the cytokine profile and anticongestive medication in patients with chronic chagasic cardiopathy;Revista da Sociedade Brasileira de Medicina Tropical;2019

3. Early Trypanosoma cruzi Infection Triggers mTORC1-Mediated Respiration Increase and Mitochondrial Biogenesis in Human Primary Cardiomyocytes;Frontiers in Microbiology;2018-08-16

4. Actividad contra Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae) de extractos metanólicos de plantas de uso medicinal en México;Revista de Biología Tropical;2017-09-19

5. Effects of a novel β–lapachone derivative on Trypanosoma cruzi : Parasite death involving apoptosis, autophagy and necrosis;International Journal for Parasitology: Drugs and Drug Resistance;2016-12